special situation – Katalyst Wealth

Apr’25 – Latest special situation opportunity

April 17, 2025

Yesterday, we released our latest Special situation opportunity for our Alpha + members and would like to share with you details on the same. As you might be aware, special situations constitute opportunities arising out of announced corporate transactions such as De-listing, Open offers, rights issue, de-merger, bankruptcy restructurings, etc. In markets, nothing is risk free; however, if carefully analyzed, one can always look for opportunities with low downside risk. At the same time, the holding period in general for such opportunities is 3-5 months.…

[New Apr’24 Special situation opportunity] – Changes in ownership in fast growing business

April 14, 2024

Hello Sir, Hope you are doing well. Today we will release new Special situation opportunity for our Alpha + members and would like to share with you details on the same. The detailed note will be released HERE Special situations constitute opportunities arising out of announced corporate transactions such as De-listing, Open offers, rights issue, de-merger, bankruptcy restructurings, etc. In markets, every investment opportunity comes with certain risks; however, with proper research and analysis, one can always evaluate and participate in opportunities with seemingly low…

[Special Situation] – Jasch Industries and Jasch Gauging…demerger case

March 17, 2024

Hello Sir, Hope you are doing well. On 19th Sep’23, we released Jasch Industries (BSE Code – 500220) Special situation opportunity for our Alpha + members and would like to share with you details on the same. It was a demerger based opportunity wherein Jasch was running 2 diverse businesses and intended to demerge the industrial gauges business and list it separately. The terms of the demerger were simple – The gauges business was to list separately as Jasch Gauging while Jasch Industries retained the…

[Special Situation] – Glenmark Lifesciences…open offer and promoter change case

January 11, 2024

Hello Sir, Hope you are doing well. On 13th Oct’23, we released Glenmark Lifesciences (NSE Code – GLS) Special situation opportunity for our Alpha + members and would like to share with you details on the same. The corporate action is still ongoing and we haven’t closed the opportunity as yet. Basically, we initiated it in Oct’23 around 650 odd levels and the current price is around 720. In between, the company also paid out Rs 22.50/- per share dividend. What was the special situation in this opportunity? – Basically, on 21st…